最新情報：ジカウイルス曝露の可能性のある人を対象とした受胎前カウンセリングおよびジカウイスルの性感染予防のための暫定ガイダンス ― アメリカ、2016年9月

日本語
English

ホーム IMICライブラリ MMWR抄訳 2016年（Vol.65)最新情報：ジカウイルス曝露の可能性のある人を対象と･･･

MMWR抄訳

2016/10/07Vol. 65 / No. 39

MMWR65(39):1077－1081
Update: Interim Guidance for Preconception Counseling and Prevention of Sexual Transmission of Zika Virus for Persons with Possible Zika Virus Exposure — United States, September 2016

最新情報：ジカウイルス曝露の可能性のある人を対象とした受胎前カウンセリングおよびジカウイスルの性感染予防のための暫定ガイダンス ― アメリカ、2016年9月

CDCは、妊娠を計画しているジカウイルス曝露の可能性のある人のための暫定ガイダンス、および性的接触を介したジカウイルス感染予防のための暫定ガイダンスを更新し、ひとつの文書に統合した。ジカウイルス曝露の可能性のある妊婦に対するケアに関するガイダンスは、既に発表してある。ジカウイルス曝露の可能性は、ジカウイルス伝染の活発な地域への旅行または居住、あるいは伝染の活発な地域への旅行または居住しているパートナーとのコンドームなしの性交と定義される。限定されてはいるが新規のデータに基づいて、現在CDCはパートナーとの妊娠の計画を考慮しているジカウイルス曝露の可能性のある全ての男性に対し、症状の状態にかかわらず、症状発現後(症状がある場合)または最後のジカウイルス曝露の可能性後(無症状の場合)、少なくても6カ月までは妊娠の待機を推奨している。妊娠を計画している女性に対する勧告に変更はなく、ジカウイルス曝露の可能性のある女性では、症状発現後(症状がある場合)または最後のジカウイルス曝露の可能性後(無症状の場合)、少なくても8週までは妊娠の待機が推奨されている。妊娠していないか妊娠を計画しないジカウイルス曝露の可能性のあるカップルで、ジカウイルスの性感染リスクを最小にしたい場合は、コンドームを使用するか、あるいは上記に記載した男性および女性の感染防止の同じ期間について禁欲するべきである。ジカウイルス曝露のある、または今後のジカウイルス曝露が見込まれる再生産年齢の女性で妊娠を希望しない場合は、最も効果的な避妊法を正確および持続的に使用する必要がある。これらの勧告は、追加データが利用可能となった場合にさらに更新される。

References

Petersen EE, Polen KN, Meaney-Delman D, et al. Update: interim guidance for health care providers caring for women of reproductive age with possible Zika virus exposure—United States, 2016. MMWR Morb Mortal Wkly Rep 2016;65:315–22. ＜http://dx.doi.org/10.15585/mmwr.mm6512e2＞
Brooks JT, Friedman A, Kachur RE, LaFlam M, Peters PJ, Jamieson DJ. Update: interim guidance for prevention of sexual transmission of Zika virus—United States, July 2016. MMWR Morb Mortal Wkly Rep 2016;65:745–7. ＜http://dx.doi.org/10.15585/mmwr.mm6529e2＞
Oduyebo T, Igbinosa I, Petersen EE, et al. Update: interim guidance for health care providers caring for pregnant women with possible Zika virus exposure—United States, July 2016. MMWR Morb Mortal Wkly Rep 2016;65:739–44. ＜http://dx.doi.org/10.15585/mmwr.mm6529e1＞
Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. Zika virus and birth defects—reviewing the evidence for causality. N Engl J Med 2016;374:1981–7. ＜http://dx.doi.org/10.1056/NEJMsr1604338＞
Daiminger A, Bäder U, Enders G. Pre- and periconceptional primary cytomegalovirus infection: risk of vertical transmission and congenital disease. BJOG 2005;112:166–72. ＜http://dx.doi.org/10.1111/j.1471-0528.2004.00328.x＞
Enders G, Miller E, Nickerl-Pacher U, Cradock-Watson JE. Outcome of confirmed periconceptional maternal rubella. Lancet 1988;331:1445–7. ＜http://dx.doi.org/10.1016/S0140-6736(88)92249-0＞
Picone O, Vauloup-Fellous C, Cordier AG, et al. A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome. Prenat Diagn 2013;33:751–8. ＜http://dx.doi.org/10.1002/pd.4118＞
Revello MG, Zavattoni M, Furione M, Lilleri D, Gorini G, Gerna G. Diagnosis and outcome of preconceptional and periconceptional primary human cytomegalovirus infections. J Infect Dis 2002;186:553–7. ＜http://dx.doi.org/10.1086/341831＞
Nunoue T, Kusuhara K, Hara T. Human fetal infection with parvovirus B19: maternal infection time in gestation, viral persistence and fetal prognosis. Pediatr Infect Dis J 2002;21:1133–6. ＜http://dx.doi.org/10.1097/00006454-200212000-00009＞
Foy BD, Kobylinski KC, Chilson Foy JL, et al. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg Infect Dis 2011;17:880–2 ＜http://dx.doi.org/10.3201/eid1705.101939.＞
Hills SL, Russell K, Hennessey M, et al. Transmission of Zika virus through sexual contact with travelers to areas of ongoing transmission—Continental United States, 2016. MMWR Morb Mortal Wkly Rep 2016;65:215–6. ＜http://dx.doi.org/10.15585/mmwr.mm6508e2＞
Venturi G, Zammarchi L, Fortuna C, et al. An autochthonous case of Zika due to possible sexual transmission, Florence, Italy, 2014. Euro Surveill 2016;21:30148. ＜http://dx.doi.org/10.2807/1560-7917.ES.2016.21.8.30148＞
Deckard DT, Chung WM, Brooks JT, et al. Male-to-male sexual transmission of Zika virus—Texas, January 2016. MMWR Morb Mortal Wkly Rep 2016;65:372–4. ＜http://dx.doi.org/10.15585/mmwr.mm6514a3＞
Davidson A, Slavinski S, Komoto K, Rakeman J, Weiss D. Suspected female-to-male sexual transmission of Zika virus—New York City, 2016. MMWR Morb Mortal Wkly Rep 2016;65:716–7. ＜http://dx.doi.org/10.15585/mmwr.mm6528e2＞
Fréour T, Mirallié S, Hubert B, et al. Sexual transmission of Zika virus in an entirely asymptomatic couple returning from a Zika epidemic area, France, April 2016. Euro Surveill 2016;21:30254. ＜http://dx.doi.org/10.2807/1560-7917.ES.2016.21.23.30254＞
Brooks RB, Carlos MP, Myers RA, et al. Likely sexual transmission of Zika virus from a man with no symptoms of infection—Maryland, 2016. MMWR Morb Mortal Wkly Rep 2016;65:915–6. ＜http://dx.doi.org/10.15585/mmwr.mm6534e2＞
D’Ortenzio E, Matheron S, de Lamballerie X, et al. Evidence of sexual transmission of Zika virus. N Engl J Med 2016;374:2195–8. ＜http://dx.doi.org/10.1056/NEJMc1604449＞
Turmel JM, Abgueguen P, Hubert B, et al. Late sexual transmission of Zika virus related to persistence in the semen. Lancet 2016;387:2501. ＜http://dx.doi.org/10.1016/S0140-6736(16)30775-9＞
Musso D, Roche C, Robin E, Nhan T, Teissier A, Cao-Lormeau VM. Potential sexual transmission of Zika virus. Emerg Infect Dis 2015;21:359–61. ＜http://dx.doi.org/10.3201/eid2102.141363＞
Mansuy JM, Suberbielle E, Chapuy-Regaud S, et al. Zika virus in semen and spermatozoa. Lancet Infect Dis 2016;16:1106–7. ＜http://dx.doi.org/10.1016/S1473-3099(16)30336-X＞
Mansuy JM, Dutertre M, Mengelle C, et al. Zika virus: high infectious viral load in semen, a new sexually transmitted pathogen? Lancet Infect Dis 2016;16:405. ＜http://dx.doi.org/10.1016/S1473-3099(16)00138-9＞
Atkinson B, Hearn P, Afrough B, et al. Detection of Zika virus in semen. Emerg Infect Dis 2016;22:940. ＜http://dx.doi.org/10.3201/eid2205.160107＞
Reusken C, Pas S. GeurtsvanKessel C, et al. Longitudinal follow-up of Zika virus RNA in semen of a traveller returning from Barbados to the Netherlands with Zika virus disease, March 2016. Euro Surveill 2016;21:30251. ＜http://dx.doi.org/10.2807/1560-7917.ES.2016.21.23.30251＞
Matheron S, d’Ortenzio E, Leparc-Goffart I, Hubert B, de Lamballerie X, Yazdanpanah Y. Long-lasting persistence of Zika virus in semen. Clin Infect Dis 2016. E-pub July 28, 2016. ＜http://dx.doi.org/10.1093/cid/ciw509＞
Harrower J, Kiedrzynski T, Baker S, et al. Sexual transmission of Zika virus and persistence in semen, New Zealand, 2016. Emerg Infect Dis 2016;22:1855–7. ＜http://dx.doi.org/10.3201/eid2210.160951＞
Mansuy JM, Pasquier C, Daudin M, et al. Zika virus in semen of a patient returning from a non-epidemic area. Lancet Infect Dis 2016;16:894–5. ＜http://dx.doi.org/10.1016/S1473-3099(16)30153-0＞
Frank C, Cadar D, Schlaphof A, et al. Sexual transmission of Zika virus in Germany, April 2016. Euro Surveill 2016;21:30252. ＜http://dx.doi.org/10.2807/1560-7917.ES.2016.21.23.30252＞
Huits B, Arien KK, Van Esbroeck M, de Jong BC, Bottieau E, Cnops L. Kinetics of Zika virus persistence in semen. Bull World Health Organ 2016. E-pub July 6, 2016. ＜http://www.who.int/bulletin/online_first/16-181370.pdf＞
Barzon L, Pacenti M, Franchin E, et al. Infection dynamics in a traveller with persistent shedding of Zika virus RNA in semen for six months after returning from Haiti to Italy, January 2016. Euro Surveill 2016;21:30316. 10.2807/1560-7917.ES.2016.21.32.30316
Nicastri E, Castilletti C, Liuzzi G, Iannetta M, Capobianchi MR, Ippolito G. Persistent detection of Zika virus RNA in semen for six months after symptom onset in a traveller returning from Haiti to Italy, February 2016. Euro Surveill 2016;21:30314. ＜http://dx.doi.org/10.2807/1560-7917.ES.2016.21.32.30314＞
Arsuaga M, Bujalance SG, Díaz-Menéndez M, Vázquez A, Arribas JR. Probable sexual transmission of Zika virus from a vasectomised man. Lancet Infect Dis 2016;16:1107. ＜http://dx.doi.org/10.1016/S1473-3099(16)30320-6＞
Lanciotti RS, Kosoy OL, Laven JJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 2008;14:1232–9. ＜http://dx.doi.org/10.3201/eid1408.080287＞
Driggers RW, Ho CY, Korhonen EM, et al. Zika virus infection with prolonged maternal viremia and fetal brain abnormalities. N Engl J Med 2016;374:2142–51. ＜http://dx.doi.org/10.1056/NEJMoa1601824＞
Meaney-Delman D, Oduyebo T, Polen KN, et al.; U.S. Zika Pregnancy Registry Prolonged Viremia Working Group. Prolonged detection of Zika virus RNA in pregnant women. Obstet Gynecol 2016;128:724–30. ＜http://dx.doi.org/10.1097/AOG.0000000000001625＞
Lustig Y, Mendelson E, Paran N, Melamed S, Schwartz E. Detection of Zika virus RNA in whole blood of imported Zika virus disease cases up to 2 months after symptom onset, Israel, December 2015 to April 2016. Euro Surveill 2016;21:30269. ＜http://dx.doi.org/10.2807/1560-7917.ES.2016.21.26.30269＞
Busch MP, Kleinman SH, Tobler LH, et al. Virus and antibody dynamics in acute West Nile virus infection. J Infect Dis 2008;198:984–93. ＜http://dx.doi.org/10.1086/591467＞
CDC. CDC updates guidance for travel and testing of pregnant women and women of reproductive age for Zika virus infection related to the ongoing investigation of local mosquito-borne Zika virus transmission in Miami-Dade County, Florida. Atlanta, GA: US Department of Health and Human Services, CDC; 2016. ＜https://emergency.cdc.gov/han/han00396.asp＞
CDC. Guidance for U.S. laboratories testing for Zika virus infection. Atlanta, GA: US Department of Health and Human Services, CDC; 2016. ＜http://www.cdc.gov/zika/laboratories/lab-guidance.html＞
CDC. Preconception counseling for women and men living in areas with ongoing spread of Zika virus who are interested in conceiving. Atlanta, GA: US Department of Health and Human Services, CDC; 2016. ＜https://www.cdc.gov/zika/pdfs/preconception-counseling.pdf＞
CDC. Effectiveness of family planning methods. Atlanta, GA: US Department of Health and Human Services, CDC; 2016. ＜https://www.cdc.gov/reproductivehealth/unintendedpregnancy/pdf/contraceptive_methods_508.pdf＞
Food and Drug Administration. Donor screening recommendations to reduce the risk of transmission of Zika virus by human cells, tissues, and cellular and tissue-based products. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2016. ＜http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Tissue/UCM488582.pdf＞
Curtis KM, Jatlaoui TC, Tepper NK, et al. U.S. selected practice recommendations for contraceptive use, 2016. MMWR Recomm Rep 2016;65(No. RR-4). ＜http://dx.doi.org/10.15585/mmwr.rr6504a1＞